抗肺结核药物研究进展

被引:4
作者
刘继东
周伟澄
机构
[1] 上海医药工业研究院
[2] 上海医药工业研究院 上海
[3] 上海
关键词
结核分支杆菌; 抗结核药物; 综述;
D O I
暂无
中图分类号
R978.3 [抗结核病药、抗麻风病药物];
学科分类号
1007 ;
摘要
由于艾滋病和细菌耐药性的出现 ,结核病日益成为全球健康关注问题。目前迫切需要新的化学治疗药物。本文介绍一些具有抗结核分支杆菌活性的新化合物 ,如氟喹诺酮、唑烷酮、烷磺基乙酰胺和硝基咪唑类化合物的研究进展
引用
收藏
页码:45 / 49
页数:5
相关论文
共 24 条
[11]  
A small -molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Stover CK,Warrener P,Vandevanter DR,et al. Nature . 2000
[12]  
I n vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis. Ashtekar DR. Antimicrobial Agents and Chemotherapy . 1993
[13]  
Dihydrophenazines as antibacterial agents against mycobacterium. Mikio K,Hisashi M,Motohiro I,et al. JP: 1156258 . 1999
[14]  
I n vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis. Rensburg V,Constance EJ,Giselark J. Chemotherapy . 2000
[15]  
Antimycobacterial activities of isoxy1 and new derivatives through the inhibition of mycolic acid synthesis. Phetsuksiri B,Baulard AR,Cooper AM,et al. Antimicrobial Agents and Chemotherapy . 1999
[16]  
Mefloquine is active in vitro and in vivo against Mycobacterium avium complex. Bermudez LE,Kolonoski P,Wu M,et al. Antimicrobial Agents and Chemotherapy . 1999
[17]  
Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant intramacrophagic Mycobacterium tuberculosis strains. Deidda D,Lampis G,Fioravanti R,et al. Antimicrobial Agents and Chemotherapy . 1998
[18]  
A new class of antituberculosis agents. Jones BF,Parrish NM,Houston TA,et al. Journal of Medicinal Chemistry . 2000
[19]  
Identification of a novel oxazolidione ( U-100480 )with potent antimycobacterial activity. Barbachyn MR,Hutchingon DK,Brickner SJ,et al. Journal of Medicinal Chemistry . 1996
[20]  
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. Cynamon M H,Klemens S P,Sharpe C A,et al. Antimicrobial Agents and Chemotherapy . 1999